These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 17330781)

  • 1. Relapses of Plasmodium vivax infection usually result from activation of heterologous hypnozoites.
    Imwong M; Snounou G; Pukrittayakamee S; Tanomsing N; Kim JR; Nandy A; Guthmann JP; Nosten F; Carlton J; Looareesuwan S; Nair S; Sudimack D; Day NP; Anderson TJ; White NJ
    J Infect Dis; 2007 Apr; 195(7):927-33. PubMed ID: 17330781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resolving the cause of recurrent Plasmodium vivax malaria probabilistically.
    Taylor AR; Watson JA; Chu CS; Puaprasert K; Duanguppama J; Day NPJ; Nosten F; Neafsey DE; Buckee CO; Imwong M; White NJ
    Nat Commun; 2019 Dec; 10(1):5595. PubMed ID: 31811128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relapses of Plasmodium vivax infection result from clonal hypnozoites activated at predetermined intervals.
    Chen N; Auliff A; Rieckmann K; Gatton M; Cheng Q
    J Infect Dis; 2007 Apr; 195(7):934-41. PubMed ID: 17330782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microsatellite genotyping of Plasmodium vivax infections and their relapses in pregnant and non-pregnant patients on the Thai-Myanmar border.
    Thanapongpichat S; McGready R; Luxemburger C; Day NP; White NJ; Nosten F; Snounou G; Imwong M
    Malar J; 2013 Aug; 12():275. PubMed ID: 23915022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genotyping of Plasmodium vivax reveals both short and long latency relapse patterns in Kolkata.
    Kim JR; Nandy A; Maji AK; Addy M; Dondorp AM; Day NP; Pukrittayakamee S; White NJ; Imwong M
    PLoS One; 2012; 7(7):e39645. PubMed ID: 22808048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular and immunological analyses of confirmed Plasmodium vivax relapse episodes.
    Maneerattanasak S; Gosi P; Krudsood S; Chimma P; Tongshoob J; Mahakunkijcharoen Y; Sukasem C; Imwong M; Snounou G; Khusmith S
    Malar J; 2017 May; 16(1):228. PubMed ID: 28558712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of an Unsupervised Primaquine Regimen for Preventing Plasmodium vivax Malaria Relapses in Northeast Myanmar: A Single-Arm Nonrandomized Observational Study.
    Malla P; Wang Z; Brashear A; Yang Z; Lo E; Baird K; Wang C; Cui L
    J Infect Dis; 2024 May; 229(5):1557-1564. PubMed ID: 38041857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radical curative efficacy of five-day regimen of primaquine for treatment of Plasmodium vivax malaria in India.
    Yadav RS; Ghosh SK
    J Parasitol; 2002 Oct; 88(5):1042-4. PubMed ID: 12435158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of therapeutic efficacy of chloroquine for vivax malaria in Thailand.
    Vijaykadga S; Rojanawatsirivej C; Congpoung K; Wilairatana P; Satimai W; Uaekowitchai C; Pumborplub B; Sittimongkol S; Pinyorattanachote A; Prigchoo P
    Southeast Asian J Trop Med Public Health; 2004 Sep; 35(3):566-9. PubMed ID: 15689067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic assessment of chloroquine-primaquine combined regimen in adult cohort of Plasmodium vivax malaria from a tertiary care hospital in southwestern India.
    Rishikesh K; Kamath A; Hande MH; Vidyasagar S; Acharya RV; Acharya V; Belle J; Shastry AB; Saravu K
    Malar J; 2015 Aug; 14():310. PubMed ID: 26259839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasmodium vivax resistance to chloroquine in Dawei, southern Myanmar.
    Guthmann JP; Pittet A; Lesage A; Imwong M; Lindegardh N; Min Lwin M; Zaw T; Annerberg A; de Radiguès X; Nosten F
    Trop Med Int Health; 2008 Jan; 13(1):91-8. PubMed ID: 18291007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of vivax malaria on the western border of Thailand.
    Luxemburger C; van Vugt M; Jonathan S; McGready R; Looareesuwan S; White NJ; Nosten F
    Trans R Soc Trop Med Hyg; 1999; 93(4):433-8. PubMed ID: 10674098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimation of the Antirelapse Efficacy of Tafenoquine, Using Plasmodium vivax Genotyping.
    Beck HP; Wampfler R; Carter N; Koh G; Osorio L; Rueangweerayut R; Krudsood S; Lacerda MV; Llanos-Cuentas A; Duparc S; Rubio JP; Green JA
    J Infect Dis; 2016 Mar; 213(5):794-9. PubMed ID: 26500351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrent parasitemias and population dynamics of Plasmodium vivax polymorphisms in rural Amazonia.
    Orjuela-Sánchez P; da Silva NS; da Silva-Nunes M; Ferreira MU
    Am J Trop Med Hyg; 2009 Dec; 81(6):961-8. PubMed ID: 19996423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population pharmacokinetics of a three-day chloroquine treatment in patients with Plasmodium vivax infection on the Thai-Myanmar border.
    Höglund R; Moussavi Y; Ruengweerayut R; Cheomung A; Äbelö A; Na-Bangchang K
    Malar J; 2016 Feb; 15():129. PubMed ID: 26928448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Directly-observed therapy (DOT) for the radical 14-day primaquine treatment of Plasmodium vivax malaria on the Thai-Myanmar border.
    Takeuchi R; Lawpoolsri S; Imwong M; Kobayashi J; Kaewkungwal J; Pukrittayakamee S; Puangsa-art S; Thanyavanich N; Maneeboonyang W; Day NP; Singhasivanon P
    Malar J; 2010 Nov; 9():308. PubMed ID: 21040545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo sensitivity monitoring of chloroquine for the treatment of uncomplicated vivax malaria in four bordered provinces of Thailand during 2009-2010.
    Congpuon K; Satimai W; Sujariyakul A; Intanakom S; Harnpitakpong W; Pranuth Y; Cholpol S; Bualombai P
    J Vector Borne Dis; 2011 Dec; 48(4):190-6. PubMed ID: 22297279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic efficacy of chloroquine and chloroquine plus primaquine for the treatment of Plasmodium vivax in Ethiopia.
    Yeshiwondim AK; Tekle AH; Dengela DO; Yohannes AM; Teklehaimanot A
    Acta Trop; 2010 Feb; 113(2):105-13. PubMed ID: 19835832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional differences in the response of Plasmodium vivax malaria to primaquine as anti-relapse therapy.
    Goller JL; Jolley D; Ringwald P; Biggs BA
    Am J Trop Med Hyg; 2007 Feb; 76(2):203-7. PubMed ID: 17297026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of combined chloroquine and primaquine treatment in 14 days versus intermittent single dose regimen, in an open, non-randomized, clinical trial, to eliminate Plasmodium vivax in southern Mexico.
    Gonzalez-Ceron L; Rodriguez MH; Sandoval MA; Santillan F; Galindo-Virgen S; Betanzos AF; Rosales AF; Palomeque OL
    Malar J; 2015 Oct; 14():426. PubMed ID: 26518132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.